<DOC>
	<DOCNO>NCT01597986</DOCNO>
	<brief_summary>The purpose study assess effect multiple dose isavuconazole pharmacokinetics ( PK ) single dose contraceptive healthy post-menopausal woman .</brief_summary>
	<brief_title>Drug Interaction Study Isavuconazole Oral Contraceptive Containing Ethinyl Estradiol Norethindrone</brief_title>
	<detailed_description />
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Mestranol</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone acetate , ethinyl estradiol , ferrous fumarate drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Norinyl</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<criteria>The subject body weight least 45 kg body mass index ( BMI ) 18 32 kg/m2 , inclusive Results aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , total bilirubim must upper limit normal range The subject must postmenopausal , define least 2 year since last regular menstrual cycle follicle stimulate hormone ( FSH ) &gt; 30 IU/L The subject treatment hormone replacement therapy within 3 month prior Day 1 The subject history adverse event take oral contraceptive hormone replacement therapy The subject history unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia torsade de pointes , structural heart disease , family history Long QT syndrome ( suggest sudden death close relative young age due possible probable cardiac cause ) The subject positive result hepatitis C antibodies hepatitis B surface antigen Screening know positive human immunodeficiency virus ( HIV ) The subject know suspect allergy component trial product azole class compound , history multiple and/or severe allergy drug food ( judge investigator ) , history severe anaphylactic reaction The subject smoker ( use tobacco nicotine containing product ) within 6 month prior Screening The subject treatment prescription drug complementary alternative medicine within 14 day prior Day 1 , overthecounter medication within 1 week prior Day 1 , exception acetaminophen 2 g/day The subject recent history ( within last 2 year ) drug alcohol abuse , define investigator , positive drug and/or alcohol screen</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>isavuconazole</keyword>
	<keyword>ethinyl estradiol</keyword>
	<keyword>norethindrone</keyword>
	<keyword>contraceptive</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>BAL8557</keyword>
	<keyword>BAL4815</keyword>
</DOC>